Amy Easter is a Patent Attorney at Quell Therapeutics since September 2020, with prior experience as a European Patent Attorney and Patent Attorney at Kilburn & Strode LLP from September 2012 to September 2020. Amy also held a Patent Attorney position at MSD through a secondment from Kilburn & Strode between September 2018 and June 2019. Academic qualifications include a PhD in Medicine from the University of Cambridge, awarded for research on TRUSS in TNF-R1 signaling and its implications for inflammatory lung diseases, and a Bachelor of Science in Human Biology from the University of Birmingham.